AI assistant
Sirnaomics Ltd. Director's Dealing 2026
50478_rns_2026-03-30_f21cda8b-3bc7-4959-8558-5ffae1d2077c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Sirnaomics Ltd.
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 2257)
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY A DIRECTOR
This announcement is made by Sirnaomics Ltd. (the "Company"), together with its subsidiaries, the "Group") on a voluntary basis.
The board (the "Board") of directors of the Company was informed by Dr. Poon Hung Fai ("Dr. Poon"), an executive director and the chairman of the Company, that Dr. Poon purchased a total of 38,000 ordinary shares of the Company ("Shares") at an average price of approximately HK$5.93 per Share on open market on March 30, 2026 with his personal funds. Immediately after the purchase, Dr. Poon is interested in an aggregate of 17,665,696 Shares, representing 16.10% of the total issued share capital of the Company as at the date of this announcement.
As advised by Dr. Poon, he is fully confident about the overall development prospect and potential growth of the Group. In compliance with applicable laws and regulatory requirements, Dr. Poon does not rule out that he may further increase his shareholding in the Company as when appropriate.
- 1 -
Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.
By order of the Board
Sirnaomics Ltd.
Poon Hung Fai
Chairman and Executive Director
Hong Kong, March 30, 2026
As at the date of this announcement, the Board comprises Dr. Poon Hung Fai as executive Director, Mr. Ouyang Yunlong and Dr. Yin Huijun as non-executive Directors, and Mr. Wong Yu Shan Eugene, Dr. Zhang Peng and Ms. Lo Yee Hang as independent non-executive Directors.
– 2 –